The prognostic value of interleukin 15 combinate with the model for end-stage liver disease score in patients with chronic hepatitis B
Li Ha
Abstract
Li Ha
Abstract
Objective To investigate the prognostic value of interleukin 15 combinate with the model for end-stage liver disease score in patients with chronic hepatitis B.Methods Interleukin 15 combinate with the model for end-stage liver disease score,MELD score and Child-Pugh score of 105 patients with liver cirrhosis,91 patients with hepatitis B and 101 patients with severe hepatitis were recorded,and the prognostic value were compared.Results Interleukin 15 combinate with the model for end-stage liver disease score,MELD scores and Child-Pugh score had significant difference between died group and living group(P0.05).The area under ROC of interleukin 15 combinate the model for end-stage liver disease score,MELD scores and Child-Pugh score were 0.825,0.814,and 0.779 respectively.There were significant difference between interleukin 15 combinate the model for end-stage liver disease score,MELD score and Child-Pugh score(P0.05),no significant difference between interleukin 15 combinate the model for end-stage liver disease score and MELD score(P0.05).Prognostic value of each scores were lower in liver cirrhosis group than in hepatitis B and severe hepatitis groups,and in severe hepatitis groups,there were significant difference between interleukin 15 combinate with the model for end-stage liver disease score and Child-Pugh score(P0.05).Conclusions The prognostic value of interleukin 15 combinate with the model for end-stage liver disease score system is superior than that of Child-Pugh score in patients with chronic hepatitis B.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the prognostic value of interleukin 15 combinate with the model for end-stage liver disease score in patients with chronic hepatitis B.Methods Interleukin 15 combinate with the model for end-stage liver disease score,MELD score and Child-Pugh score of 105 patients with liver cirrhosis,91 patients with hepatitis B and 101 patients with severe hepatitis were recorded,and the prognostic value were compared.Results Interleukin 15 combinate with the model for end-stage liver disease score,MELD scores and Child-Pugh score had significant difference between died group and living group(P0.05).The area under ROC of interleukin 15 combinate the model for end-stage liver disease score,MELD scores and Child-Pugh score were 0.825,0.814,and 0.779 respectively.There were significant difference between interleukin 15 combinate the model for end-stage liver disease score,MELD score and Child-Pugh score(P0.05),no significant difference between interleukin 15 combinate the model for end-stage liver disease score and MELD score(P0.05).Prognostic value of each scores were lower in liver cirrhosis group than in hepatitis B and severe hepatitis groups,and in severe hepatitis groups,there were significant difference between interleukin 15 combinate with the model for end-stage liver disease score and Child-Pugh score(P0.05).Conclusions The prognostic value of interleukin 15 combinate with the model for end-stage liver disease score system is superior than that of Child-Pugh score in patients with chronic hepatitis B.
Key concepts: Medicine, Internal medicine, Cirrhosis, Gastroenterology, Liver disease, Model for End-Stage Liver Disease, Stage (stratigraphy), Hepatitis